Name: Enterocin
Brand: Biolinks K.K.
SKU: BLK-0950

For Research Use Only. Not for human or veterinary use.

Enterocin (CAS: 59678-46-5) Product ID: BLK-0950 CAS 59678-46-5 Mechanism Pore-forming bacteriocin Primary Target Bacterial cytoplasmic membrane Pathway Bacterial membrane integrity; ABC transporter-mediated immunity
Structure
CAS	59678-46-5
Molecular Formula	C22H20O10
Molecular Weight	444.39
Price	1mg: USD 150.00 / 5mg: - / 25mg: -
Storage	-20°C
Solubility	1mg/ml ethanol, methanol, DMSO
Purity	>95% [View LC/UV Data]
Source Organism	Streptomyces sp.
Summary	Enterocin is a ribosomally synthesized antimicrobial peptide that disrupts Gram-positive bacterial membranes.
Details	Enterocin refers to a family of bacteriocins produced by Enterococcus species that inhibit closely related Gram-positive bacteria. These peptides act primarily by inserting into the bacterial membrane, forming pores that disrupt membrane integrity and lead to leakage of cellular contents, chromosomal condensation, and cell lysis. Immunity and cross-resistance mechanisms are mediated by dedicated ABC transporter systems that protect producer strains. Due to strong antimicrobial and biofilm-inhibitory properties, enterocins are widely investigated as natural food biopreservatives and as potential alternatives or adjuvants to antibiotics.
Browse Related	Mechanism Pore-forming bacteriocin Open full index Primary Target Bacterial cytoplasmic membrane Open full index Pathway Bacterial membrane integrity; ABC transporter-mediated immunity Open full index Chemical Class Ribosomally synthesized peptide (bacteriocin) Open full index
Mechanism	Pore-forming bacteriocin
Primary Target	Bacterial cytoplasmic membrane
Pathway	Bacterial membrane integrity; ABC transporter-mediated immunity
Chemical Class	Ribosomally synthesized peptide (bacteriocin)
Discovery Year	1978
Keywords	bacteriocin peptide membrane-permeabilizing agent gram-positive bacteria inhibitor pore-forming peptide enterococcus-derived peptide antimicrobial research tool
References	Klaenhammer et al., Arch Microbiol, 1978 DOI: 10.1007/BF02565084 Soni et al., Microorganisms, 2022 DOI: 10.3390/microorganisms10040684 Grande Burgos et al., Microorganisms, 2021 DOI: 10.3390/microorganisms9071411 Benmouna et al., Antibiotics, 2023 DOI: 10.3390/antibiotics12071188
Request pricing, availability, or bulk supply information for this compound. Get a Quote General Inquiry
Documents 📄 Safety Data Sheet (SDS) – Download PDF 📄 Product Specification Sheet (PDS) – Download PDF 🧪 Certificate of Manufacture (CofM) – Download HTML
← Back to Catalog
Representative LC/UV Data HPLC Conditions (typical): Column: C18 Mobile phase: 5–100% ACN / H2O (0.05% H3PO4), linear gradient 20 min Flow rate: 0.2 mL/min Detection: 210 nm Representative analytical data. Actual batch data may vary.

Enterocin (CAS: 59678-46-5)